THE IMPACT OF MERGERS AND ACQUISITIONS ON THE PERFORMANCE OF EUROPEAN PHARMACEUTICAL COMPANIES: A CURRENT STATUS REVIEW

The purpose of the study is to generalize and systematize scientific ideas about the impact of mergers and acquisitions on the effectiveness of European pharmaceutical companies based on the analysis of modern empirical and theoretical works. The research materials include scientific publications on mergers and acquisitions in the pharmaceutical industry in Europe, as well as research results on the pricing, innovation and corporate effects of mergers and acquisitions. The article uses methods of comparative and structural analysis, deductive generalization, and analytical comparison of studies. Research result: a holistic view of the multidimensional nature of the impact of mergers and acquisitions on the effectiveness of pharmaceutical companies has been formed, taking into account differences in indicators and evaluation horizons. Conclusions: a) the effectiveness of mergers and acquisitions in the European pharmaceutical industry is not reduced to a single indicator; b) discrepancies in research results are due to differences in methods and interpretations; c) a correct assessment of the impact of mergers and acquisitions involves taking into account management decisions after their completion.